Merck & Co. Inc. Stock Advances 12.6%, Outperforms Peers

Dow Jones
08/20

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Merck & Co. Inc. jumped 12.6% to $152.20 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.2% to 7,707.98 and the Dow Jones Industrial Average rising 0.2% to 53,463.05.

Merck & Co. Inc. hit a new 52-week high, surpassing its previous peak of $137.98, which the company reached on August 18th.

The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $273.41, Pfizer Inc. rose 3.6% to $28.24, and Eli Lilly & Co. rose 4.46% to $1,280.34.

Trading volume totaled 32.4 million, compared to the 50-day average of 10.1 million.

Data source: Dow Jones Market Data, FactSet

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10